ANTIBODY-DRUG CONJUGATE PERTUZUMAB-MCC-DM1, COMPOSITION OF PERTUZUMAB-MCC-DM1 AND TRASTUZUMAB AND USES THEREOF

摘要

Provided are antibody-drug conjugate Pertuzumab-MCC-DM1 (that is, P-DM1) and a treating agent composition comprising the P-DM1 and an HER2 dimerisation inhibitor antibody. Also provided are uses of the P-DM1 and the treating agent composition in treating highly proliferative diseases.